Paper165156
Classification and biological nature of established human hematopoietic cell lines.
Nilsson K and 1 other. Int J Cancer, 1975. Cited by 365 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Classification and biological nature of established human hematopoietic cell lines. Papers, record 165156. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/165156
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Line | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Antigens, Viral | |
| Burkitt Lymphoma | |
| Chromosomes | |
| Culture Media | |
| Cytotoxicity Tests, Immunologic | |
| Herpesvirus 4, Human | |
| Histocompatibility Testing | |
| Humans | |
| Immunoglobulins | |
| In Vitro Techniques | |
| Leukemia | |
| Lymphocytes | |
| Lymphoma | |
| Microscopy, Electron, Scanning | |
| Multiple Myeloma | |
| Radioimmunoassay | |
| T-Lymphocytes |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 365 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,861,347 | Fab-Arm Exchange Combined with Selective Protein A Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly from Culture Media. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31861347 | PubMed |
| 31,080,361 | Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells. | Cancer Cell Int | 2019 | https://conductscience.org/library/papers/31080361 | PubMed |
| 27,941,868 | Mosaicism in health and disease - clones picking up speed. | Nat Rev Genet | 2017 | https://conductscience.org/library/papers/27941868 | PubMed |
| 23,781,115 | Republished: Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. | Postgrad Med J | 2013 | https://conductscience.org/library/papers/23781115 | PubMed |
| 23,172,682 | Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. | J Med Genet | 2013 | https://conductscience.org/library/papers/23172682 | PubMed |
| 19,881,539 | Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. | Oncogene | 2010 | https://conductscience.org/library/papers/19881539 | PubMed |
| 17,322,915 | Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. | Oncogene | 2007 | https://conductscience.org/library/papers/17322915 | PubMed |
| 15,005,240 | Persistent use of false myeloma cell lines. | Hum Cell | 2003 | https://conductscience.org/library/papers/15005240 | PubMed |
| 8,087,305 | Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease. | In Vitro Cell Dev Biol Anim | 1994 | https://conductscience.org/library/papers/8087305 | PubMed |
| 7,397,412 | [In vitro studies on two cell lines from patients with Hodgkin's disease (author's transl)]. | Blut | 1980 | https://conductscience.org/library/papers/7397412 | PubMed |
| 7,031,655 | Monoclonal antibody against a Burkitt lymphoma-associated antigen. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/7031655 | PubMed |
| 6,974,176 | Marker profiles of human leukemia and lymphoma cell lines. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/6974176 | PubMed |
| 6,967,850 | Lack of expression on cultured human T-lymphocytes of a T-cell antigen shared by the MOLT-4 cell line and normal human thymocytes. | In Vitro | 1980 | https://conductscience.org/library/papers/6967850 | PubMed |
| 6,783,354 | Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6783354 | PubMed |
| 6,572,959 | Generation of human monoclonal antibodies reactive with cellular antigens. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6572959 | PubMed |
| 6,490,006 | Heterochromatin and nucleolus organizer regions in cells of patients with malignant and premalignant lymphatic diseases. | Hum Genet | 1984 | https://conductscience.org/library/papers/6490006 | PubMed |
| 6,470,143 | Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6470143 | PubMed |
| 6,329,564 | Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6329564 | PubMed |
| 6,319,530 | Epstein-Barr virus susceptibility of normal human B lymphocyte populations. | J Exp Med | 1984 | https://conductscience.org/library/papers/6319530 | PubMed |
| 6,315,041 | Lymphoma-associated antigen (LAA): isolation, characterization and clinical evaluation. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6315041 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/165156
GET https://conductscience.org/api/papers/v1/165156/cited_by?page=2